EMERYVILLE, Calif.--(BUSINESS WIRE)--Dr. Ron Najafi, CEO of NovaBay Pharmaceuticals, Inc. (AMEX & TSX: NBY, http://www.novabaypharma.com), a clinical stage biopharmaceutical company developing non-antibiotic anti-infective compounds that do not develop resistance, for the treatment or prevention of a wide range of bacterial, fungal, and viral infections, will present at the 4th Annual Summer Technology Conference hosted by Security Research Associates, Inc. The conference will be held on Monday, August 18, 2008 at the Omni Hotel in San Francisco.
